In a first, New Jersey awards stem-cell grants
By Philadelphia Inquirer,
Philadelphia Inquirer
| 12. 17. 2005
The state became the first in the nation yesterday to fund stem-cell research, awarding grants to 17 researchers at universities, nonprofit institutions and corporate labs.
The grants of up to $300,000 each fund two years of research and were made possible by a $5 million allocation in the $28 billion state budget that acting Gov. Richard J. Codey signed in July. The New Jersey Commission on Science and Technology chose the recipients from 71 applicants. The researchers will study both adult stem cells, culled from spinal-cord fluid, and embryonic stem cells, which are formed in the first days of pregnancy.
Although California voters approved a $3 billion bond for stem-cell research last year, that state has yet to award any money, making New Jersey the first state to fund stem-cell research.
The New Jersey State Senate approved legislation Thursday that would place a $350 million bond referendum for stem-cell research grants on the ballot in November, but the bill's fate in the Assembly is uncertain during the lame-duck legislative session
Related Articles
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
